Transcutaneous Pulsed Radiofrequency Application Plus Genicular Nerve Block Versus Intraarticular Hyaluronic Acid Injection for Management of Chronic Pain in Knee Osteoarthritis.
CompletedNot applicableNCT06710782
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The aim of the present study is to compare the analgesic efficacy of combined transcutaneous pulsed radiofrequency plus genicular nerve block with bupivacaine plus corticosteroid versus intraarticular Hyaluronic acid injections, in terms of clinical and functional parameters, in patients with knee osteoarthritis.
Study details
- Official title
- A Comparative Study Between Transcutaneous Pulsed Radiofrequency Application Plus Genicular Nerve Block Versus Intra-Articular Hyaluronic Acid Injection for Management of Chronic Pain in Knee Osteo-arthritis: A Prospective Randomized Controlled Study.
- Conditions
- Transcutaneous
- Pulsed Radiofrequency
- Genicular Nerve Block
- Intraarticular
- Hyaluronic Acid
- Chronic Pain
- Knee Osteoarthritis
- Interventions
- Drug: Hyaluronic acid
- Device: Transcutaneous pulsed radiofrequency
- Sponsor
- Tanta University
- Start date
- 2023-08-01
- Primary completion
- 2024-07-01
- Sex
- All
- Age range
- from 40 Years
- Results posted
- No results posted in this snapshot
- Countries
- Egypt
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Aged above 40 years. * Both sexes * American Society of Anesthesiologists (ASA)physical status I and II. * Patients radiologically proven symptomatic knee joint osteoarthritis not responding to medical treatment. * Patients with knee pain of moderate or greater intensity on most or all days for ≥ 3 months, showing significant radiological osteoarthritis (Kellgren-Lawrence grade 1 to 3). Radiological severity was assessed using the Kellgrenand Lawrence global scale as follow: Grade 0; means absence of radiological finding; grade 1: suspected narrowing of joint space; grade 2 refers to osteophytes and possible narrowing; grade 3 is defined as multiple os-teophytes, definite narrowing of joint space and grade 4 comprises large osteophytes, marked narrowing of joint space. Exclusion Criteria: * Patient refusal. * Patients who show improvement on medical treatment, patients on an oral, topical, or intra-articular steroid during the 4 weeks before the study; patients with an oral, topical, or suppository non-steroidal anti-inflammatory drugs within 2 weeks before the study. * Patients having secondary knee osteoarthritis. * Patients with severe osteoarthritis.(K/L grade \>3) in a location other than the knee joint. * Patients with rheumatoid arthritis. * Patients with joint replacement surgery in either knee and/or a hip. * Patients with meniscal tear, ligament injury, bursitis, and popliteal cyst and blood investigations suggestive of any infection. * Morbid obese patients (body mass index (BMI) of \>40 kg/m2) * Infection at site of injection. * Bleeding diathesis and coagulopathy.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT06710782